thiorphan has been researched along with avapro in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batenburg, WW; Bhaggoe, UM; Clahsen-van Groningen, MC; de Vries, R; Domenig, O; Friesema, EC; Garrelds, IM; Hoorn, EJ; Jan Danser, AH; Leijten, FP; Poglitsch, M; Roksnoer, LC; van Veghel, R | 1 |
| Batenburg, WW; Danser, AH; de Vries, R; Li, Q; Li, Y; Prasad, T; Roksnoer, LC; Verma, A; Zhu, P | 1 |
| Badawy, AES; Habib, E; Hasanin, AH; Hussein Mohamed, R; Khairy, E; Mahmoud, D; Mohammed Abdulsalam, T | 1 |
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
1 review(s) available for thiorphan and avapro
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
3 other study(ies) available for thiorphan and avapro
| Article | Year |
|---|---|
Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arterial Pressure; Atrial Natriuretic Factor; Biphenyl Compounds; Body Weight; Endothelin B Receptor Antagonists; Endothelin-1; Irbesartan; Kidney; Myocardium; Myocytes, Cardiac; Neprilysin; Oligopeptides; Organ Size; Piperidines; Protease Inhibitors; Rats; Receptor, Angiotensin, Type 1; Receptor, Endothelin B; Renin-Angiotensin System; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Tetrazoles; Thiorphan; Up-Regulation; Vasoconstriction; Vasodilation | 2015 |
Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glial Fibrillary Acidic Protein; Irbesartan; Male; Neprilysin; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA; Tetrazoles; Thiorphan | 2016 |
Angiotensin receptor-neprilysin inhibitor (thiorphan/irbesartan) improved cardiac function in a rat model of myocardial ischemic reperfusion injury.
Topics: Animals; Cardiotonic Agents; Endothelin-1; Irbesartan; Male; Myocardial Reperfusion Injury; Myocardium; Neprilysin; Rats; Rats, Wistar; Receptors, Angiotensin; Thiorphan | 2023 |